The glucocorticoid mometasone furoate is a novel FXR ligand that decreases inflammatory but not metabolic gene expression

The Farnesoid X receptor (FXR) regulates bile salt, glucose and cholesterol homeostasis by binding to DNA response elements, thereby activating gene expression (direct transactivation). FXR also inhibits the immune response via tethering to NF-κB (tethering transrepression). FXR activation therefore...

Descripción completa

Detalles Bibliográficos
Autores principales: Bijsmans, Ingrid T. G. W., Guercini, Chiara, Ramos Pittol, José M., Omta, Wienand, Milona, Alexandra, Lelieveld, Daphne, Egan, David A., Pellicciari, Roberto, Gioiello, Antimo, van Mil, Saskia W. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572934/
https://www.ncbi.nlm.nih.gov/pubmed/26369990
http://dx.doi.org/10.1038/srep14086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572934/
https://www.ncbi.nlm.nih.gov/pubmed/26369990
http://dx.doi.org/10.1038/srep14086

Ejemplares similares